NHS WAITING LIST: 12–18 MONTHS

Start losing weight
this week. Not next year.

Doctor-prescribed Wegovy and Mounjaro — the same NICE-approved treatments as the NHS, available to you online within 48 hours.

GMC Registered
FFPM Qualified
NICE-Guided Prescribing
CQC Compliant
48-Hour Appointment

The NHS can't help you right now.
We can.

Millions of people in the UK qualify for GLP-1 therapy but face years of waiting or nowhere to turn. Here's what they're up against.

12–18 month NHS waits for Wegovy

NHS weight management services are at capacity. Patients are being told to join a waiting list and come back in over a year — even those with serious weight-related health conditions.

🏥

GPs won't prescribe Mounjaro

Most GPs cannot prescribe GLP-1 medications directly. They refer to specialist weight management services — which are equally overwhelmed and using the same waiting lists.

⚠️

Online pharmacies with no doctor oversight

A growing number of online pharmacies offer GLP-1 medications without adequate medical assessment, blood testing or ongoing monitoring. This is not safe care. Wrong dosing and undetected contraindications cause real harm.

Metovia is doctor-led, NICE-guided, and takes you from consultation to prescription in 48 hours.

Wegovy and Mounjaro — what the science says

Both medications are NICE-approved, extensively trialled, and prescribed only after a full medical assessment by Dr Qurbain.

NICE TA875 Approved

Wegovy

Semaglutide — weekly injection

15%
Average body weight loss in STEP trials
  • GLP-1 receptor agonist — reduces appetite and slows gastric emptying
  • Weekly subcutaneous injection, self-administered
  • Doses from 0.25mg titrating up to 2.4mg maintenance dose
  • NICE approved for BMI ≥ 30, or ≥ 27 with a weight-related condition
  • Also available as Ozempic (diabetes indication) at lower doses
NICE TA924 Approved

Mounjaro

Tirzepatide — weekly injection

20–22%
Average body weight loss in SURMOUNT trials
  • Dual GIP and GLP-1 receptor agonist — the first of its class
  • Weekly subcutaneous injection, self-administered
  • Doses from 2.5mg titrating up to 15mg maintenance dose
  • NICE approved for BMI ≥ 35, or ≥ 30 with a weight-related condition
  • Currently the most effective licensed weight management medication available
Dr Qurbain will recommend the most appropriate medication based on your full medical assessment, including your BMI, metabolic profile, medical history and personal preferences.

Am I eligible?

Use the calculator below to get an instant indication. BMI is one factor — your full eligibility is assessed by Dr Qurbain at consultation.

Height
Weight
Your BMI
You are likely eligible for GLP-1 therapy. Book your consultation →
⚠️
You may be eligible with a weight-related health condition (e.g. type 2 diabetes, hypertension). Book to discuss →
ℹ️
GLP-1 therapy is not currently indicated at your BMI. Dr Qurbain offers metabolic health consultations to support healthy weight management.

This is an indicative check only. Final eligibility is determined by Dr Qurbain at consultation, taking into account your full medical history and any weight-related health conditions.

Your programme, step by step

1
Today

Book online

Choose your appointment slot. Complete a pre-consultation questionnaire covering your weight history, medical history, current medications and lifestyle. This takes around 10 minutes and gives Dr Qurbain everything needed to make your consultation as effective as possible.

2
Before your appointment

Blood tests

Order a home blood test kit from one of our recommended partners. Results are typically back in 3–5 days. We review HbA1c, fasting glucose, lipids, thyroid function, liver function and kidney function — a comprehensive metabolic panel to ensure safe and appropriate prescribing.

3
Within 48 hours of receiving results

Video consultation with Dr Qurbain

A 45-minute one-to-one video consultation. Dr Qurbain reviews your full metabolic profile, discusses your goals and health history, answers your questions and agrees your programme. If appropriate, your prescription is issued during or immediately after this appointment.

4
Within 24 hours of consultation

Prescription & medication

Your electronic prescription is sent to your chosen registered UK pharmacy. Medication is delivered directly to your door. You also receive a supervised titration schedule — a clear, personalised plan for dose increases over your programme.

5
Ongoing

Monthly monitoring

Monthly 20-minute video check-ins with Dr Qurbain. Dose titration as needed, prescription renewal, blood monitoring at key intervals, and messaging support between appointments. Your progress is tracked throughout your programme and reviewed at every visit.

Transparent pricing. No hidden fees.

Two simple fees cover your medical care. Medication is dispensed separately by a registered UK pharmacy at your cost.

Ongoing care
Monthly Monitoring
£150/mo
After initial consultation
  • 20-minute monthly video check-in
  • Dose titration and adjustment
  • Monthly prescription renewal
  • Blood monitoring at key intervals
  • Messaging support between appointments
Get started →
Medication cost
GLP-1 Medication
Not included
Dispensed by registered UK pharmacies
  • Wegovy (semaglutide): £150–200/month
  • Mounjaro (tirzepatide): £180–260/month
  • Dispensed by CQC-registered UK pharmacies
  • Delivered directly to your home
  • Cost varies by dose and pharmacy
Read FAQs →

Most patients begin seeing results — reduced appetite, improved energy — within 4–8 weeks of starting treatment.

About Dr Qurbain

Dr Anzal Qurbain
Dr Anzal Qurbain
Dr Anzal Qurbain
MBBS BSc(Hons) MBA FFPM
GMC Registration: 4369286

Dr Qurbain is a Fellow of the Faculty of Pharmaceutical Medicine (FFPM) — one of approximately 700 in the UK. This qualification represents the highest level of expertise in pharmaceutical medicine, covering drug development, clinical pharmacology and evidence-based prescribing. Fellowship is awarded only to doctors who have passed a rigorous professional examination and demonstrated sustained expertise in the discipline.

Unlike nurse-led or questionnaire-only online prescribing services, every Metovia patient is assessed and prescribed by a doctor with specialist pharmaceutical medicine qualifications. Dr Qurbain reviews your full metabolic picture — not just your weight. Blood results, medication history, comorbidities and risk factors are all considered before any prescription is issued.

Dr Qurbain has worked across the pharmaceutical industry with major manufacturers of GLP-1 medications and has a deep understanding of the clinical evidence base, safety profile and optimal use of these treatments. This specialist knowledge directly informs the quality and rigour of prescribing decisions made at Metovia.

Questions & answers

Yes. GLP-1 medications have been through extensive clinical trials involving tens of thousands of patients and are NICE-approved for use in the UK. Dr Qurbain conducts a full medical assessment — including blood panel review — before prescribing, and monitors you throughout your treatment programme to ensure safety and appropriate dose titration.
Online pharmacies offering GLP-1 medications without a full medical assessment are not providing safe care. At Metovia, your care includes a comprehensive blood panel review before your appointment, a 45-minute one-to-one consultation with a doctor who holds specialist pharmaceutical medicine qualifications, a personalised programme and titration schedule, and ongoing monthly monitoring. This is the standard of care GLP-1 therapy requires.
Dr Qurbain will explain exactly why GLP-1 therapy is not appropriate and discuss alternative metabolic health support options. Your consultation fee covers the full medical assessment regardless of outcome — you are paying for Dr Qurbain's time and expertise, not for a guaranteed prescription.
Clinical trials show an average of 15% total body weight loss with Wegovy (semaglutide) over 68 weeks, and 20–22% with Mounjaro (tirzepatide) over 72 weeks. Most patients notice meaningful appetite suppression within the first 2–4 weeks of treatment. Individual results vary depending on starting weight, dose, adherence and lifestyle factors.
No. The entire Metovia programme is delivered online. Consultations are conducted by video, blood tests are completed using a home testing kit, prescriptions are electronic, and medication is delivered to your door. You receive the same standard of medical care without needing to travel.
Wegovy and Mounjaro are both available on the NHS, but waiting lists are currently 12–18 months in most areas due to overwhelming demand. Private prescribing through Metovia is entirely legal and uses the same NICE-approved medications at the same doses — you simply don't have to wait over a year to start.
We recommend an at-home blood test covering HbA1c (to check for diabetes), fasting glucose, lipid profile (cholesterol), thyroid function, liver function and kidney function. This comprehensive metabolic panel provides the clinical information Dr Qurbain needs to prescribe safely. We can recommend a home testing kit provider at the time of booking.
Most patients use GLP-1 therapy for 12–24 months while establishing sustainable healthy habits and reaching their target weight. Research suggests that weight regain can occur after stopping treatment, particularly without lifestyle changes. Dr Qurbain will review the ongoing need for medication at every monthly monitoring appointment and discuss the appropriate exit strategy for your circumstances.

Ready to start?
Book your consultation today.

Appointments available within 48 hours. Doctor-led. NICE-guided. No waiting list.

Book a consultation — £300 →

Or email hello@metovia.co.uk with any questions